Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets
Clinical trial NCT03420534 · UNKNOWN
Trial details
- NCT number
- NCT03420534
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-17
- Primary completion
- 2017-12-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.